Paper Details
- Home
- Paper Details
Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension.
Author: KinoshitaYoshikazu, NakajimaAtsushi, OotaAkira, ShinboKazuhiko
Original Abstract of the Article :
BACKGROUND: Although polyethylene glycol 3350 plus electrolytes (PEG3350 + E) is the most widely used osmotic laxative in Europe, prospective data on its long-term (over 6 months) safety and efficacy are not available to date. METHODS: Japanese patients with chronic constipation were randomized to ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698298/
データ提供:米国国立医学図書館(NLM)
Polyethylene Glycol 3350 Plus Electrolytes for Chronic Constipation: A 2-Week Study with a 52-Week Extension
Constipation, a common ailment that affects many, is like a camel trying to navigate a narrow desert path - it's a slow, uncomfortable process. This study delves into the effectiveness of polyethylene glycol 3350 plus electrolytes (PEG3350 + E) for treating chronic constipation in Japanese patients. The researchers took a two-pronged approach, conducting a two-week randomized, double-blind, placebo-controlled study, followed by a 52-week open-label extension. The researchers sought to understand the long-term safety and efficacy of PEG3350 + E, a question that had not been fully addressed before. The study revealed that PEG3350 + E was effective in resolving constipation in the short term and well-tolerated, leading to sustained improvement in bowel function over the long term. This is promising news for those seeking a solution to constipation, especially since PEG3350 + E is a commonly used treatment in Europe.
PEG3350 + E: A ray of hope for chronic constipation
The study showed that PEG3350 + E significantly improved the frequency of spontaneous bowel movements (SBMs) compared to placebo. This finding suggests that the drug is effective in alleviating constipation symptoms. The improvement in bowel function was sustained throughout the 52-week extension period, reinforcing the long-term efficacy of PEG3350 + E.
Navigating a smoother desert path: What does this mean for your gut?
For those grappling with chronic constipation, the study provides a glimmer of hope. The results suggest that PEG3350 + E could be a viable long-term treatment option. It's important to remember that everyone is different and what works for one person may not work for another. It's always recommended to consult a healthcare professional to find the right treatment for your specific needs.
Dr. Camel's Conclusion
This study, like a well-placed oasis in the desert, provides a welcome solution for those struggling with chronic constipation. The sustained efficacy and good tolerance of PEG3350 + E are promising findings, offering hope for a smoother journey through the desert of digestive discomfort.
Date :
- Date Completed 2020-06-15
- Date Revised 2020-06-15
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.